Auckland BioSciences (ABS) has opened a new $2 million animal serum filtration facility in Auckland that allows the New Zealand life sciences company to provider higher-value products to global customers.
The company, which expects to hit $46m in consolidated group annual revenue in the 2023
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
